Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence-Reference-Cited by-同舟云学术

Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence

Published:2022-04-20 Issue:5 Volume:36 Page:777-789
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundamemntal Clinical Pharma

Author:

Moradian Farid¹,Pourhanifeh Mohammad Hossein²^ORCID,Mehrzadi Saeed³^ORCID,Karimi‐Behnagh Arman⁴,Hosseinzadeh Azam³^ORCID

Affiliation:

1. Departement of General Surgery Alborz University of Medical Science Alborz Iran

2. Research Center for Biochemistry and Nutrition in Metabolic Diseases, Institute for Basic Sciences Kashan University of Medical Sciences Kashan Iran

3. Razi Drug Research Center Iran University of Medical Sciences Tehran Iran

4. Faculty of Medicine Iran university of Medical sciences Tehran Iran

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12780

Reference143 articles.

1. Cancer statistics, 2017

2. Living with hematologic cancer: Recommendations, solutions

3. Incidence and survival of hematological cancers among adults ages ≥75 years

4. Acute lymphoblastic leukemia: a comprehensive review and 2017 update

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Effects of Melatonin in the Regulation of Ferroptosis: A Review of Current Evidence;Current Drug Targets;2024-06

2. Melatonin: Current evidence on protective and therapeutic roles in gynecological diseases;Life Sciences;2024-05

3. Melatonin Alleviates High Glucose-induced Oxidative Stress and Mitochondrial Dysfunction in Chondrocytes;Current Drug Therapy;2023-11-06

4. Melatonin in Chemo/Radiation Therapy; Implications for Normal Tissues Sparing and Tumor Suppression: An Updated Review;Current Medicinal Chemistry;2023-11-02

5. Evaluating the Protective Effect of Melatonin on Atorvastatin-induced Mitochondrial Toxicity in Pancreatic Beta Cells;Current Drug Safety;2023-11-01